AGNISTABIO Trademark
Trademark Overview
On Monday, April 29, 2024, a trademark application was filed for AGNISTABIO with the United States Patent and Trademark Office. The USPTO has given the AGNISTABIO trademark a serial number of 98525680. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 17, 2024. This trademark is owned by AgnistaBio Inc.. The AGNISTABIO trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:
Pharmaceutical preparations for the treatment of inflammatory diseases, immune related diseases, disorders and conditions; biological preparations for the treatment of inflammatory diseases, immune related diseases, disorders and conditions; pharmaceutical preparations for the treatment of cancer, tumor, malignancies, and related diseases, disorders, and conditions; biological preparations for the treatment of cancer, tumor, malignancies, and related diseases, disorders, and conditions; pharmaceutical preparations for the treatment of eye diseases; biological preparations for the treatment of eye diseases; pharmaceutical preparations for the treatment of cardiovascular diseases; biological preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of brain disorders; biological preparations for the treatment of brain disorders
Licensing of intellectual property; Licensing of intellectual property in the field of pharmaceuticals; Licensing of intellectual property in the field of medical and scientific technologies; legal services
Providing medical information in the field of inflammatory disease, immune related diseases, disorders and conditions prevention, screening, diagnosis and treatment; providing medical information in the field of cancer, tumor, malignancies, and related diseases, disorders, and conditions prevention, screening, diagnosis and treatment; providing medical information in the field of eye diseases, cardiovascular diseases, and brain disorder prevention, screening, diagnosis and treatment
Medical and scientific research in the field of inflammatory diseases, immune related diseases, disorders, and conditions treatment and diagnosis; medical and scientific research in the field of cancer, tumors, malignancies, and related diseases, disorders and conditions treatment and diagnosis; Medical and scientific research in the field of eye diseases, cardiovascular diseases and brain disorders treatment and diagnosis; Clinical research in the field of inflammatory diseases, immune related diseases, disorders, and conditions; Clinical research in the field of cancer, tumors, malignancies, and related diseases, disorders and conditions; Clinical research in the field of eye diseases, cardiovascular diseases and brain disorders, and conditions; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research and development; Scientific research and development; Conducting early evaluations in the field of new pharmace...
General Information
| Serial Number | 98525680 |
| Word Mark | AGNISTABIO |
| Filing Date | Monday, April 29, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, December 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 17, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of inflammatory diseases, immune related diseases, disorders and conditions; biological preparations for the treatment of inflammatory diseases, immune related diseases, disorders and conditions; pharmaceutical preparations for the treatment of cancer, tumor, malignancies, and related diseases, disorders, and conditions; biological preparations for the treatment of cancer, tumor, malignancies, and related diseases, disorders, and conditions; pharmaceutical preparations for the treatment of eye diseases; biological preparations for the treatment of eye diseases; pharmaceutical preparations for the treatment of cardiovascular diseases; biological preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of brain disorders; biological preparations for the treatment of brain disorders |
| Goods and Services | Licensing of intellectual property; Licensing of intellectual property in the field of pharmaceuticals; Licensing of intellectual property in the field of medical and scientific technologies; legal services |
| Goods and Services | Providing medical information in the field of inflammatory disease, immune related diseases, disorders and conditions prevention, screening, diagnosis and treatment; providing medical information in the field of cancer, tumor, malignancies, and related diseases, disorders, and conditions prevention, screening, diagnosis and treatment; providing medical information in the field of eye diseases, cardiovascular diseases, and brain disorder prevention, screening, diagnosis and treatment |
| Goods and Services | Medical and scientific research in the field of inflammatory diseases, immune related diseases, disorders, and conditions treatment and diagnosis; medical and scientific research in the field of cancer, tumors, malignancies, and related diseases, disorders and conditions treatment and diagnosis; Medical and scientific research in the field of eye diseases, cardiovascular diseases and brain disorders treatment and diagnosis; Clinical research in the field of inflammatory diseases, immune related diseases, disorders, and conditions; Clinical research in the field of cancer, tumors, malignancies, and related diseases, disorders and conditions; Clinical research in the field of eye diseases, cardiovascular diseases and brain disorders, and conditions; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research and development; Scientific research and development; Conducting early evaluations in the field of new pharmaceuticals; Research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical and biopharmaceutical research services in the fields of inflammatory diseases, immune related diseases, disorders, and conditions, cancer, tumors, malignancies, and related diseases, disorders, conditions, eye diseases, cardiovascular diseases, and brain disorders; Pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; Pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services; Software as a service services featuring artificial intelligence software for drug discovery and development; Scientific and technological services and research and design relating thereto in the nature of pharmaceutical research and development; Industrial analysis and research services in the nature of pharmaceutical research and development; Design and development of computer hardware and software |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 29, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 29, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 29, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 29, 2024 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | AgnistaBio Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Palo Alto, CA 94301 |
| Party Name | AgnistaBio Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Palo Alto, CA 94301 |
Trademark Events
| Event Date | Event Description |
| Monday, April 29, 2024 | NEW APPLICATION ENTERED |
| Wednesday, October 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 14, 2024 | ASSIGNED TO EXAMINER |
| Thursday, November 21, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 21, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, November 21, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 21, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, November 21, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 11, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 17, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 17, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
